Skip to main content
Caplight Logo









Biomixing

Biomixing

Private
SevillaHealthcare & Life Scienceshttps://biomixing.com/

Last Round

Accelerator

Sep 11, 2024

Total Funding Raised

$17,520

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biomixing is a biotechnology company that has developed a patented agitation and aeration system for bioreactors to enhance efficiency and reduce processing time.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioreactor agitationbioreactor aerationbioprocessingbiomanufacturingbioreactor optimizationprocess intensificationshear stress reductionbioprocess engineeringcustom bioreactorsbioreactor retrofittingbioprocess scale-upfermentation systemscomputational fluid dynamicsCFDcultured meatlab-grown meatadvanced therapiesregenerative medicineGMP manufacturingGood Manufacturing Practice

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomixing Comparables

Compare Biomixing with similar companies based on industry and business-model similarity.

Biomixing comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PBS Biotech
75%
Bouygues
74%
Donaldson Company
70%

Biomixing Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 11, 2024
GrantOct 27, 2023
GrantMay 26, 2022

Key People

Founding team and executive leadership

Carlos López Viso

Chief Operating Officer

Executive Team

Biomixing Investors

Notable investors and investment history

Biomixing investors
InvestorRounds
ICEX Spain Export and InvestmentAccelerator
RootCampAccelerator
MassChallenge SwitzerlandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 6, 3x the trailing average.

  • Jun 8, 2025

    Grew 36% QoQ, from 11 to 15 employees.

Biomixing Filings

Explore SEC and related filing metadata, where available.

Biomixing filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biomixing's valuation, stock price, and market status.

Is Biomixing a public or private company?

Biomixing is a private company.

What is the current stock price of Biomixing?

Biomixing is a private company with no public stock price. No recent secondary market data is available.

How much is Biomixing worth (valuation)?

Valuation information for Biomixing is not publicly available.

Can I buy Biomixing stock?

Biomixing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biomixing's last funding round?

Biomixing's most recent funding round was Accelerator on September 11, 2024.

Who are the main investors in Biomixing?

Key investors in Biomixing include ICEX Spain Export and Investment, RootCamp, MassChallenge Switzerland.

Will Biomixing IPO soon?

No public IPO plans have been announced for Biomixing.

How can I track Biomixing secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomixing's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSevilla
Employee Range12
Year Founded2022
Last FundingSep 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?